Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation

Molecular Cancer Therapeutics

Volumn 2, Issue 11, 2003, Pages 1093-1103

  Kondapaka, Sudhir B ^a   Singh, Sheo S ^a   Dasmahapatra, Girija P ^a   Sausville, Edward A ^a   Roy, Krishnendu K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GROWTH PROMOTOR; ONCOPROTEIN; PERIFOSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHORYLCHOLINE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL DIVISION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; MALE; MOLECULAR STRUCTURE; PHOSPHORYLATION; PHOSPHORYLCHOLINE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 2542547908     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Unger, C., Damenz, W., Fleer, E. A., Kim, D. J., Breiser, A., Hilgard, P., Engel, J., Nagel, G., and Eibl, H. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. Acta Oncol., 28: 213-217, 1989. (Pubitemid 19159628)
2. Berdel, W. E., Bausert, W. R., Fink, U., Rastetter, J., and Munder, P. G. Anti-tumor action of alkyl-lysophospholipids (Review). Anticancer Res., 1: 345-352, 1981.
3. Principe, P., Sidoti, C., Coulomb, H., Broquet, C., and Braquet, P. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids. Cancer Detect. Prev., 18: 393-400, 1994. (Pubitemid 2156069)
4. Leonard, R., Hardy, J., van Tienhoven, G., Houston, S., Simmonds, P., David, M., and Mansi, J. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J. Clin. Oncol., 19: 4150-4159, 2001. (Pubitemid 33049533)
5. Terwogt, J. M., Mandjes, I. A., Sindermann, H., Beijnen, J. H., and ten Bokkel Huinink, W. W. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer. Br. J. Cancer, 79: 1158-1161, 1999. (Pubitemid 29087890)
6. Smorenburg, C. H., Seynaeve, C., Bontenbal, M., Planting, A. S., Sindermann, H., and Verweij, J. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients. Anticancer Drugs, 11: 825-828, 2000.
7. Jha, T. K., Sundar, S., Thakur, C. P., Bachmann, P., Karbwang, J., Fischer, C., Voss, A., and Berman, J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med., 341: 1795-1800, 1999.
8. Eibl, H. Miltefosine for visceral leishmaniasis. N. Engl. J. Med., 342: 894-895, 2000.
9. Hilgard, P., Klenner, T., Stekar, J., Nossner, G., Kutscher, B., and Engel, J. D-21266, a new heterocyclic alkylphospholipid with antitumor activity. Eur. J. Cancer, 33: 442-446, 1997. (Pubitemid 27168072)
10. Woo, E. W., Messmann, R., Sausville, E. A., and Figg, W. D. Quantitative determination of perifosine, a novel alkylphosphocholine anticancer agent, in human plasma by reversed-phase liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl., 759: 247-257, 2001. (Pubitemid 32575285)
11. Arthur, G. and Bittman, R. The inhibition of cell signaling pathways by antitumor ether lipids. Biochim. Biophys. Acta, 1390: 85-102, 1998. (Pubitemid 28122329)
12. Maly, K., Uberall, F., Schubert, C., Kindler, E., Stekar, J., Brachwitz, H., and Grunicke, H. H. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anticancer Drug Des., 10: 411-425, 1995.
13. Brachwitz, H. and Vollgraf, C. Analogues of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol. Ther., 66: 39-82, 1995.
14. Kley, J. T., Unger, C., and Massing, U. Inhibition of 14-kDa PLA2 by 2-acylamino-alkylphospholipids: the influence of amide acidity. Biochim. Biophys. Acta, 1392: 193-201, 1998. (Pubitemid 28287324)
15. Berkovic, D. Cytotoxic etherphospholipid analogues. Gen. Pharmacol., 31: 511-517, 1998. (Pubitemid 28458917)
16. Ruiter, G. A., Zerp, S. F., Bartelink, H., Van Blitterswijk, W. J., and Verheij, M. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs, 14: 167-173, 2003. (Pubitemid 36269756)
17. Leroy, A., de Bruyne, G. K., Oomen, L. C., and Mareel, M. M. Alkylphospholipids reversibly open epithelial tight junctions. Anticancer Res., 23: 27-32, 2003. (Pubitemid 36358496)
18. Patel, V., Lahusen, T., Sy, T., Sausville, E. A., Gutkind, J. S., and Senderowicz, A. M. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Cancer Res., 62: 1401-1409, 2002. (Pubitemid 34407799)
19. Okumura, E., Fukuhara, T., Yoshida, H., Hanada Si, S., Kozutsumi, R., Mori, M., Tachibana, K., and Kishimoto, T. Akt inhibits Myt1 in the signaling pathway that leads to meiotic G2-M-phase transition. Nat. Cell. Biol., 4: 111-116, 2002. (Pubitemid 34141476)
20. Burgering, B. M. and Kops, G. J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci., 27: 352-360, 2002. (Pubitemid 34756518)
21. Falck, J., Mailand, N., Syljuasen, R. G., Bartek, J., and Lukas, J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 410: 842-847, 2001. (Pubitemid 32303786)
22. Brennan, P., Mehl, A. M., Jones, M., and Rowe, M. Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene, 21: 1263-1271, 2002. (Pubitemid 34185243)
23. Vivanco, I. and Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2: 489-501, 2002. (Pubitemid 37328931)
24. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., and Gray, J. W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet., 21: 99-102, 1999. (Pubitemid 29036292)
25. Bellacosa, A., de Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer, 64: 280-285, 1995.
26. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., and Testa, J. R. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA, 93: 3636-3641, 1996. (Pubitemid 26127592)
27. Ruggeri, B. A., Huang, L., Wood, M., Cheng, J. Q., and Testa, J. R. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol. Carcinog., 21: 81-86, 1998. (Pubitemid 28122842)
28. Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., and Sawyers, C. L. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. USA, 95: 5246-5250, 1998. (Pubitemid 28208583)
29. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., and Tsichlis, P. N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 81: 727-736, 1995.
30. Toker, A. and Cantley, L. C. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature, 387: 673-676, 1997. (Pubitemid 27270600)
31. Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R., Reese, C. B., Painter, G. F., Holmes, A. B., McCormick, F., and Hawkins, P. T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science, 277: 567-570, 1997. (Pubitemid 27369005)
32. Bellacosa, A., Chan, T. O., Ahmed, N. N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J., and Tsichlis, P. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene, 17: 313-325, 1998. (Pubitemid 28383008)
33. Andjelkovic, M., Alessi, D. R., Meier, R., Fernandez, A., Lamb, N. J., Frech, M., Cron, P., Cohen, P., Lucocq, J. M., and Hemmings, B. A. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem., 272: 31515-31524, 1997. (Pubitemid 28013293)
34. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15: 6541-6551, 1996. (Pubitemid 26413787)
35. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., and Cohen, P. Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol., 7: 261-269, 1997. (Pubitemid 27176852)
36. Di Cristofano, A. and Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell, 100: 387-390, 2000.
37. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275: 1943-1947, 1997. (Pubitemid 27148818)
38. Staal, S. P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA, 84: 5034-5037, 1987. (Pubitemid 17095859)
39. McMenamin, M. E., Soung, P., Perera, S., Kaplan, I., Loda, M., and Sellers, W. R. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res., 59: 4291-4296, 1999. (Pubitemid 29418745)
40. Murga, C., Fukuhara, S., and Gutkind, J. S. A novel role for phosphatidylinositol 3-kinase β in signaling from G protein-coupled receptors to Akt. J. Biol. Chem., 275: 12069-12073, 2000. (Pubitemid 30237781)
41. Murga, C., Laguinge, L., Wetzker, R., Cuadrado, A., and Gutkind, J. S. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for α and β γ subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinase g. J. Biol. Chem., 273: 19080-19085, 1998. (Pubitemid 28366302)
42. Persad, S., Attwell, S., Gray, V., Mawji, N., Deng, J. T., Leung, D., Yan, J., Sanghera, J., Walsh, M. P., and Dedhar, S. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem., 276: 27462-27469, 2001.
43. Montaner, S., Sodhi, A., Pece, S., Mesri, E. A., and Gutkind, J. S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res., 61: 2641-2648, 2001. (Pubitemid 32685850)
44. Bondeva, T., Pirola, L., Bulgarelli-Leva, G., Rubio, I., Wetzker, R., and Wymann, M. P. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK. Science, 282: 293-296, 1998. (Pubitemid 28487201)
45. Leopoldt, D., Hanck, T., Exner, T., Maier, U., Wetzker, R., and Nurnberg, B. Gβγ stimulates phosphoinositide 3-kinase-γ by direct interaction with two domains of the catalytic p110 subunit. J. Biol. Chem., 273: 7024-7029, 1998. (Pubitemid 28160369)
46. Zeisig, R., Arndt, D., Stahn, R., and Fichtner, I. Physical properties and pharmacological activity in vitro and in vivo of optimized liposomes prepared from a new cancerostatic alkylphospholipid. Biochim. Biophys. Acta, 1414: 238-248, 1998. (Pubitemid 28511054)
47. Hilgard, P., Klenner, T., Stekar, J., and Unger, C. Alkylphosphocholines: a new class of membrane-active anticancer agents. Cancer Chemother. Pharmacol., 32: 90-95, 1993. (Pubitemid 23131925)
48. Mareel, M., Bracke, M., Bruyneel, E., Van Larebeke, N., and De Mets, M. Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs. Cancer Treat. Rev., 17: 335-338, 1990.
49. Strassheim, D., Shafer, S. H., Phelps, S. H., and Williams, C. L. Small cell lung carcinoma exhibits greater phospholipase C-β1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Cancer Res., 60: 2730-2736, 2000. (Pubitemid 30318251)
50. Vanhaesebroeck, B. and Alessi, D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J., 346 (Pt 3): 561-576, 2000. (Pubitemid 30171014)
51. Belham, C., Wu, S., and Avruch, J. Intracellular signaling: PDK1 - a kinase at the hub of things. Curr. Biol., 9: R93-R96, 1999. (Pubitemid 29087534)
52. Chan, T. O., Rittenhouse, S. E., and Tsichlis, P. N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu. Rev. Biochem., 68: 965-1014, 1999. (Pubitemid 29449213)
53. Lemmon, M. A., Ferguson, K. M., and Abrams, C. S. Pleckstrin homology domains and the cytoskeleton. FEBS Lett., 513: 71-76, 2002. (Pubitemid 34242981)
54. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol., 3: 245-252, 2001.
55. Rossig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., and Dimmeler, S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol., 21: 5644-5657, 2001. (Pubitemid 32702467)
56. Cip/WAF1 and promotes cell survival. J. Biol. Chem., 277: 11352-11361, 2002.